Contacts
+1 626 345 8596
Call us: +1 626 345 8596

Publications

LatestPublications

2024 Sep 25
Press Release/Arie Shen
Proteas Health Selected as Preferred Proteomics CRO by Perha Pharmaceuticals to Drive Breakthroughs in Drug Development with Advanced Proteomics Platform
2024 Apr
Br J Surg
Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma
2024 Mar
JCI Insight
Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers
2023 Jun
bioRxiv
Functional glycoproteomics by integrated network assembly and partitioning
2022 Sep
Proc Natl Acad Sci U S A
Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication
2022 Jun
Cell Rep Med
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
2022 Jun
Virology
Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency

click here for publication list  of Protea’s founders